Structures of human mitochondrial aspartate/glutamate carrier regulatory domains reveal the nature of calcium-dependent conformational changes.

Mitochondrial carriers are a family of proteins that play the key role of transporting a chemically diverse range of molecules across the inner mitochondrial membrane. Mitochondrial aspartate/glutamate carriers are part of this family, and play a central role in human physiology, with roles in the malate-aspartate shuttle, urea cycle, gluconeogenesis and myelin synthesis.

They are unique amongst the mitochondrial carrier family in having three domains — a calcium-regulated N-terminal domain, a mitochondrial carrier domain, and a C-terminal domain. Despite their importance, little is known about the structure of these proteins, or how calcium regulates their activity.

A group led by Dr Edmund Kunji from the MRC Mitochondrial Biology Unit, Cambridge, has recently determined the structures of the N- and C-terminal domains of two types of human aspartate/glutamate carriers, in both the calcium-bound and calcium-free forms.

The structures, published in Nature Communications, reveal a novel arrangement of calcium-binding units (EF-hands) in the N-terminal domain, only one of which is responsible for calcium binding. Unexpectedly, the N-terminal domain is involved in dimerization of the carrier. Binding of calcium to the N-terminal domain triggers a large rigid-body rotation of part of the domain, opening up a vestibule that binds the C-terminal domain.

These movements provide the first explanation for how calcium binding regulates the activity of the carrier protein. Furthermore, the structures provide key molecular insights into the effect of mutations caused by the life-threatening mitochondrial disease citrin deficiency.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Study reveals regional differences in dementia drug use in nursing homes

Credit: Pietro Jeng from Pexels Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United States suggest a need for better guidance

Your nose could detect Alzheimer’s years before symptoms begin

A declining sense of smell may be one of the earliest warning signs of Alzheimer’s disease, appearing even before noticeable memory problems. New research from scientists at DZNE and Ludwig-Maximilians-Universität

New technology allows researchers to precisely, flexibly modulate brain

Human brain diseases, such as Parkinson’s disease, involve damage in more than one region of the brain, requiring technology that could precisely and flexibly address all affected regions simultaneously. Researchers